Skip to main content
. 2022 Mar 7;13:810914. doi: 10.3389/fendo.2022.810914

Figure 2.

Figure 2

Changes in WHO Clinical Progression Scale score, cumulative direct medical costs, cycle threshold (Ct) value, and proportion of patients with IgG antibody from baseline to day-90 among patients by treatment groups.